Why Amarin Stock Is Tumbling This Week
- Oops!Something went wrong.Please try again later.
- AMRN
Amarin (NASDAQ: AMRN), a small-cap cardiovascular care company, saw its shares dip by as much as 15% during the first four days of trading this week, according to data provided by S&P Global Market Intelligence. The good news is that Amarin's stock didn't fall in response to a company-specific event. Underscoring this point, the bellwether SPDR S&P Biotech ETF has dropped by an unsightly 14.9% over the prior four trading sessions.